BamSEC and AlphaSense Join Forces
Learn More

Wave Life Sciences Inc. – Material Contracts

NASDAQ: WVE    
Share price (9/29/26): $3.64    
Market cap (9/29/26): $717 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.6
from 8-K12B 6 pages Wave Life Sciences, Inc. Amended and Restated 2019 Employee Stock Purchase Plan
12/34/56
EX-10.5
from 8-K12B 7 pages Wave Life Sciences, Inc. (The “Company”) NASDAQ Inducement Non-Qualified Stock Option Grant Notice and NASDAQ Inducement Non-Qualified Stock Option Agreement
12/34/56
EX-10.4
from 8-K12B 7 pages NASDAQ Inducement Restricted Stock Unit Agreement - Incorporated Terms and Conditions
12/34/56
EX-10.3
from 8-K12B 18 pages Wave Life Sciences, Inc. Amended and Restated 2021 Equity Incentive Plan
12/34/56
EX-10.2
from 8-K12B 18 pages Wave Life Sciences Ltd. 2014 Equity Incentive Plan, as Amended
12/34/56
EX-10.1
from 8-K12B 11 pages Indemnification Agreement
12/34/56
EX-10.1
from 10-Q 9 pages Second Amendment to Lease
12/34/56
EX-10.1
from 10-Q 4 pages Wave Life Sciences Ltd. 2025 Non-Employee Director Compensation Policy
12/34/56
EX-10.1
from 8-K 15 pages Wave Life Sciences Ltd. 2021 Equity Incentive Plan, as Amended
12/34/56
EX-10.2
from 10-Q 4 pages Wave Life Sciences Ltd. 2024 Non-Employee Director Compensation Policy
12/34/56
EX-10.1
from 10-Q 4 pages Amendment No. 3 to Open Market Sale Agreement November 12, 2024
12/34/56
EX-10.1
from 8-K 16 pages Wave Life Sciences Ltd. 2021 Equity Incentive Plan, as Amended
12/34/56
EX-10.2
from 10-Q 9 pages Wave Life Sciences Ltd. (The “Company”) NASDAQ Inducement Restricted Share Unit Award Grant Notice and NASDAQ Inducement Restricted Share Unit Agreement
12/34/56
EX-10.1
from 10-Q 9 pages Wave Life Sciences Ltd. (The “Company”) NASDAQ Inducement Non-Qualified Share Option Grant Notice and NASDAQ Inducement Non-Qualified Share Option Agreement
12/34/56
EX-10.1
from 10-Q 4 pages Wave Life Sciences Ltd. 2023 Non-Employee Director Compensation Policy
12/34/56
EX-10.2
from 8-K 7 pages Wave Life Sciences Ltd. 2019 Employee Share Purchase Plan, as Amended
12/34/56
EX-10.1
from 8-K 16 pages Wave Life Sciences Ltd. 2021 Equity Incentive Plan, as Amended
12/34/56
EX-10
from 10-K 14 pages Executive Employment Agreement
12/34/56
EX-10
from 10-K 29 pages Investor Agreement by and Between Glaxo Group Limited and Wave Life Sciences Ltd. Dated as of January 26, 2023
12/34/56
EX-10
from 10-K 33 pages Share Purchase Agreement by and Between Glaxo Group Limited and Wave Life Sciences Ltd. Dated as of December 13, 2022
12/34/56